Tofacitinib (CP-690550,Tasocitinib)

inquiry

Cat No.

CEI-1070

Description

Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3.

Abbr

Tofacitinib (CP-690550, Tasocitinib)(JAK3)

Alias

JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK

CAS_No

477600-75-2

Molecular Weight

312.37

Purity

0.9966

Storage

2 years -20 centigrade Powder 2 weeks4centigradein DMSO 6 months-80centigradein DMSO

Synonyms

JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK

Targets

JAK3

IC50

1 nM

Molecular Formula

C16H20N6O

Chemical Name

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

Solubility

DMSO 63 mg/mL
Water <1 mg/mL
Ethanol <1 mg/mL

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry